HOXD13 and diffuse large B-cell lymphoma: Our study demonstrates that high sPD-1 levels in peripheral blood at the time of diagnosis are associated with poor survival in patients diagnosed with clinically high-risk DLBCL treated uniformly in a multicenter clinical trial.